Bank of New York Mellon Corp Has $50.08 Million Position in HealthEquity, Inc. $HQY

Bank of New York Mellon Corp trimmed its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 599,254 shares of the company’s stock after selling 22,625 shares during the period. Bank of New York Mellon Corp’s holdings in HealthEquity were worth $50,080,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC acquired a new position in HealthEquity during the second quarter worth $306,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of HealthEquity during the 2nd quarter valued at $4,747,000. Marshall Wace LLP bought a new position in HealthEquity in the second quarter valued at approximately $5,483,000. Amundi raised its stake in HealthEquity by 9.3% during the second quarter. Amundi now owns 30,203 shares of the company’s stock worth $3,059,000 after acquiring an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC bought a new stake in shares of HealthEquity during the second quarter worth about $449,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HQY shares. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $85.00 to $105.00 in a report on Thursday, April 9th. Barrington Research reiterated an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Wells Fargo & Company set a $111.00 price target on HealthEquity in a research note on Monday, June 1st. Finally, Citizens Jmp lifted their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

HealthEquity Trading Up 0.3%

Shares of HealthEquity stock opened at $94.64 on Friday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The company has a market capitalization of $7.91 billion, a P/E ratio of 35.45, a P/E/G ratio of 1.59 and a beta of 0.21. The company has a fifty day moving average of $90.21 and a 200 day moving average of $84.94.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, sell-side analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 17,905 shares of company stock valued at $1,651,280. Corporate insiders own 1.60% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.